Deceiving cancer to facilitate treatment
The effect of the phenotypic plasticity of cancer cells and how to exploit it
M.Raatz, MPI for Evolutionary Biology
Mathematical oncology is a growing interdisciplinary field of research that harnesses the power of cancer biology, clinical insights, and mathematics. By using computational techniques and mathematical equations to understand the dynamic nature of cancer, the field strives to quantify the ecology, evolution, and treatment of cancer. Mathematical oncology is pivotal in advancing the fight against the lethal disease by enhancing and personalizing the ability to diagnose and treat cancer.
Phenotypic plasticity of carcinomas: The search for a weakness in the fight against cancer cells
Carcinomas, cancer of epithelial cells, are known to show phenotypic plasticity, the ability to change traits based on the surroundings, making them difficult to treat. Cancer cells manage their phenotype by hijacking the immune system and relying on signals from immune cells. In a recently published study, Saumil Shah, Arne Traulsen, and Michael Raatz from the Department of Theoretical Biology at Max Planck Institute for Evolutionary Biology in Plön turned this devastating feature of cancer cells into a weakness by showing how this plasticity can be exploited.
Signals secreted by immune cells change the internal state of the cancer cells, manifesting as distinct phenotypes. When this signal is manipulated, the internal state of the cancer cell changes. As a response, the cancer cell changes its phenotype, becomes less harmful, and more responsive to treatment. Together with collaborators from the Institute for Experimental Cancer Research in Kiel, Saumil Shah and colleagues developed mathematical equations that capture the cancer cell response to these signals. They provide an understanding that will ultimately help to personalize and optimize cancer treatment.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.